Views & Analysis Rare Youth Project: Can you empower the next generation of r... The next generation of rare disease advocates need a little support in getting their voices heard as part of the Rare Youth Project.
News Wave's stock wavers on obesity drug data Wave Life Sciences has said new clinical trial results with its non-incretin therapy for weight loss are positive – but investors don't seem to agree.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.